Using dynamic treatment regimes to understand erythropoietin-stimulating agent hyporesponsiveness
Sign Up to like & getrecommendations! Published in 2018 at "Pediatric Nephrology"
DOI: 10.1007/s00467-018-3948-9
Abstract: BackgroundErythropoietin-stimulating agent hyporesponsiveness (ESAH) is associated with increased cardiovascular mortality in patients with end-stage renal disease (ESRD) on hemodialysis. Dynamic treatment regimes (DTR), a clinical decision support (CDS) tool that guides the prescription of specific… read more here.
Keywords: treatment regimes; dynamic treatment; treatment; stimulating agent ... See more keywords